Company AnnouncementTransaction adds petosemtamab, a late-stage asset with two Breakthrough Therapy Designations, to Genmab’s portfolioTransaction anticipated to be accretive to Genmab’s EBITDA by end ...
KUALA LUMPUR, MY / ACCESS Newswire / December 12, 2025 / Agape ATP Corporation (NASDAQ:ATPC) ("ATPC" or "the Company") a provider of health and wellness products and sustainable energy solutions, ...
Cosette Pharmaceuticals, Inc. (Cosette), a U.S.-based, fully integrated pharmaceutical company, confirms that on 9 December ...
Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation ...
Funding will further scale the company’s multimodal ML platform for patient selectionSAN FRANCISCO--(BUSINESS ...
- Three Phase 2 data readouts from lead programs, EVO756 and EVO301, expected in 2026 across atopic dermatitis (AD) and ...
Avenzo Therapeutics, Inc. (“Avenzo”), a clinical-stage biotechnology company developing next-generation oncology therapies, ...
Accenture (NYSE: ACN) has invested in Ryght AI, a platform provider that modernizes how clinical research is designed and ...
Concise regulatory statusPivotal trialOveporextonTakedaNarcolepsy (orexin‑2 agonist)US, EU, JPPhase III completed; filings ...
Today, ACRO announced that its Board of Directors elected Cassandra “Sandy” Kennedy, Chief Quality, Regulatory Affairs, and ...
Pharmaffiliates is proud to announce a remarkable achievement at the SME-Empowering India Awards 2025, where the organization ...
Major regulatory overhaul in the EUThe European Union’s lawmakers have agreed a provisional pharma package to modernise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback